Showing results (201-210 of 235) with videos related to

Sort By:
Pageof 24
Science Translational Medicine|July 22, 2011
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst developmentJian Wu, Hanno Matthaei, Anirban Maitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Human Mutation|October 20, 2011
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor typesSiân Jones, Meng Li, D Williams Parsons, et al.
The Oncologist|November 20, 2020
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate CancerLaura A Sena, Julia Fountain, Pedro Isaacsson Velho, et al.
Journal of the National Cancer Institute|January 16, 2010
Verification and unmasking of widely used human esophageal adenocarcinoma cell linesJurjen J Boonstra, Ronald van Marion, David G Beer, et al.
Cancer Discovery|May 16, 2012
ATM mutations in patients with hereditary pancreatic cancerNicholas J Roberts, Yuchen Jiao, Jun Yu, et al.
Science (New York, N.Y.)|March 7, 2009
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility geneSiân Jones, Ralph H Hruban, Mihoko Kamiyama, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation SequencingAnne Macgregor-Das, Jun Yu, Koji Tamura, et al.
Science (New York, N.Y.)|December 15, 1989
Voyager radio science observations of neptune and tritonG L Tyler, D N Sweetnam, J D Anderson, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Pageof 24